ASX healthcare stocks set to benefit from Royal Commission reforms
Link copied to
StockTalk is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host Dr Nigel Finch discusses the ASX stocks set to benefit from the Royal Commission led healthcare reforms.
Populating the expert panel this week is Irene Ryan, co-founder & CEO of CareVision, Michael Boyd, executive chairman of Jayex Healthcare (ASX:JHL) and Jason Waller, managing director & CEO of InteliCare.
The group discusses a range of topics, including the benefits of assistive technologies, how interactive health tech drives better patient outcomes, the flexibility of the Australian healthcare sector, each company’s addressable markets and revenue models, and much more.
So click above to tune in.